SinoFresh Healthcare, Inc. Announces Execution on New Strategic Plan
February 15 2011 - 3:39PM
SinoFresh® HealthCare, Inc., (Pink Sheets:SFSH) announced today
that its Board of Directors and Senior Management Team have
developed and begun implementation on a 4 point strategic growth
plan, incorporating the following components:
- Retained a reputable external accounting firm to audit and
prepare complete financial filings to make SFSH a fully transparent
reporting company under SEC guidelines.
- Complete current discussions with investment bankers to
finalize arrangements to secure near and long term financing.
- Complete hiring of national wholesale sales team to implement
the company's national sales and marketing plan.
- Continue R&D programs to bring additional innovative
effective products to market.
David R. Olund, CEO states, "We are very pleased to inform our
shareholders of the company's continued progress as we further
implement our plans to become a fully transparent and significant
player in the pharmaceutical industry. In the coming days and weeks
we will continue to announce our progress as we execute on our
strategic plans. We are dedicated to continuing to grow our company
through product excellence and innovation to build long term
profitability and significant shareholder value."
SinoFresh HealthCare, Inc. is a publicly traded
company (Pink Sheets:SFSH) based in Venice, Florida, that
manufactures and distributes nasal, oral and topical antiseptic
germ-killing products. SinoFresh products are marketed and
distributed globally through a network of strategic wholesale and
retail partners. SinoFresh Healthcare, Inc's, premier product,
SinoFresh Antiseptic Homeopathic Nasal spray has in laboratory
tests shown effective antiseptic capability against a variety of
pathogens such as MRSA, E-Coli, H1N1 and a broad range of other
viruses, molds, fungi and bacteria.
This press release includes forward-looking statements intended
to qualify for the safe harbor from liability established by the
Private Securities Litigation Reform Act of 1995. Our
forward-looking statements express our current expectations or
forecasts of possible future results or events, including
projections of future performance, statements of management's plans
and objectives, future contracts, and forecasts of trends and other
matters. Forward-looking statements speak only as of the date of
this filing, and we undertake no obligation to update or revise
such statements to reflect new circumstances or unanticipated
events as they occur. You can identify these statements by the fact
that they do not relate strictly to historic or current facts and
often use words such as "anticipate", "estimate", "expect",
"believe", "will likely result", "outlook", "project" and other
words and expressions of similar meaning. No assurance can be given
that the results in any forward-looking statements will be achieved
and actual results could be affected by one or more factors, which
could cause them to differ materially. For these statements, we
claim the protection of the safe harbor for forward-looking
statements contained in the Private Securities Litigation Reform
Act.
CONTACT: SinoFresh HealthCare Inc.
Investor Relations
941.375.8174 option 8